An Integrative Clinical Model for the Prediction of Pathological Complete Response in Patients with Operable Stage II and Stage III Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy.
FACTORS AFECTING LOCOREGIONAL RECURRENCE IN BREAST CANCER PATIENTS UNDERGOING SURGERY FOLLOWING NEOADJUVANT TREATMENT
